Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor Statesort icon
22/04/2016 NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II CIM Registered
05/05/2020 Therapy for COVID-19-Phase I-II SSA Registered
19/11/2015 EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS CLS Registered
29/10/2021 Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. CIGB Registered
01/02/2016 Determination of the local inflammatory response in patients with COPD by wood smoke and COPD per cigarette FNC Registered
30/06/2016 Nimotuzumab inoperable esophageal epithelial tumors, Phase IV CIM Registered
01/02/2016 CIGB-370 in patients with malignant tumors CIGB Registered
12/11/2021 Nasalferon in COVID-19 CIGB Registered
17/10/2017 Bioequivalence of Clopidogrel CIDEM Registered
10/02/2017 Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. CNCMA Registered
27/05/2016 COURAGE Study CIGB Registered
30/09/2016 D004 vs terazosin CPN Registered
27/12/2016 Homeostec for the treatment of chronic Chikungunya SSA Registered
01/02/2017 NeuroEPO in patients with Mild-Moderate Alzheimer's disease CIM Registered
01/02/2017 NeuroEPO in patients with Parkinson disease stage II-III CIM Registered
30/04/2018 Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) CIM Registered
28/11/2016 NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer CIM Registered
17/02/2017 Paclitaxel/Radiotherapy/Cisplatino for cervical cancer SSA Registered
29/12/2016 CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain FINLAY Registered
26/01/2017 ESAR-814 Study CIGB Registered